• Source: H5N1 genetic structure

The genetic structure of H5N1, a highly pathogenic avian influenza virus ([influenza A virus subtype H5N1]), is characterized by a segmented RNA genome consisting of eight gene segments that encode for various viral proteins essential for replication, host adaptation, and immune evasion.




Virus



Influenza A virus subtype H5N1 (A/H5N1) is a subtype of the influenza A virus, which causes influenza (flu), predominantly in birds. It is enzootic (maintained in the population) in many bird populations, and also panzootic (affecting animals of many species over a wide area). A/H5N1 virus can also infect mammals (including humans) that have been exposed to infected birds; in these cases, symptoms are frequently severe or fatal. All subtypes of the influenza A virus share the same genetic structure and are potentially able to exchange genetic material by means of reassortment
A/H5N1 virus is shed in the saliva, mucus, and feces of infected birds; other infected animals may shed bird flu viruses in respiratory secretions and other body fluids (such as milk). The virus can spread rapidly through poultry flocks and among wild birds. An estimated half a billion farmed birds have been slaughtered in efforts to contain the virus.
Symptoms of A/H5N1 influenza vary according to both the strain of virus underlying the infection and on the species of bird or mammal affected. Classification as either Low Pathogenic Avian Influenza (LPAI) or High Pathogenic Avian Influenza (HPAI) is based on the severity of symptoms in domestic chickens and does not predict the severity of symptoms in other species. Chickens infected with LPAI A/H5N1 virus display mild symptoms or are asymptomatic, whereas HPAI A/H5N1 causes serious breathing difficulties, a significant drop in egg production, and sudden death.
In mammals, including humans, A/H5N1 influenza (whether LPAI or HPAI) is rare. Symptoms of infection vary from mild to severe, including fever, diarrhoea, and cough. Human infections with A/H5N1 virus have been reported in 23 countries since 1997, resulting in severe pneumonia and death in about 50% of cases. Between 2003 and November 2024, the World Health Organization has recorded 948 cases of confirmed H5N1 influenza, leading to 464 deaths. The true fatality rate may be lower because some cases with mild symptoms may not have been identified as H5N1.
A/H5N1 influenza virus was first identified in farmed birds in southern China in 1996. Between 1996 and 2018, A/H5N1 coexisted in bird populations with other subtypes of the virus, but since then, the highly pathogenic subtype HPAI A(H5N1) has become the dominant strain in bird populations worldwide. Some strains of A/H5N1 which are highly pathogenic to chickens have adapted to cause mild symptoms in ducks and geese, and are able to spread rapidly through bird migration. Mammal species that have been recorded with H5N1 infection include cows, seals, goats, and skunks.
Due to the high lethality and virulence of HPAI A(H5N1), its worldwide presence, its increasingly diverse host reservoir, and its significant ongoing mutations, the H5N1 virus is regarded as the world's largest pandemic threat. Domestic poultry may potentially be protected from specific strains of the virus by vaccination. In the event of a serious outbreak of H5N1 flu among humans, health agencies have prepared "candidate" vaccines that may be used to prevent infection and control the outbreak; however, it could take several months to ramp up mass production.




Nomenclature






Structure and genome






= Structure

=
The influenza A virus has a negative-sense, single-stranded, segmented RNA genome, enclosed in a lipid envelope. The virus particle (also called the virion) is 80–120 nanometers in diameter such that the smallest virions adopt an elliptical shape; larger virions have a filamentous shape.
Core - The central core of the virion contains the viral RNA genome, which is made of eight separate segments. The nucleoprotein (NP) coats the viral RNA to form a ribonucleoprotein that assumes a helical (spiral) configuration. Three large proteins (PB1, PB2, and PA), which are responsible for RNA transcription and replication, are bound to each segment of viral RNP.
Capsid - The matrix protein M1 forms a layer between the nucleoprotein and the envelope, called the capsid.
Envelope - The viral envelope consists of a lipid bilayer derived from the host cell. Two viral proteins; hemagglutinin (HA) and neuraminidase (NA), are inserted into the envelope and are exposed as spikes on the surface of the virion. Both proteins are antigenic; a host's immune system can react to them and produce antibodies in response. The M2 protein forms an ion channel in the envelope and is responsible for uncoating the virion once it has bound to a host cell.




= Genome

=
The table below presents a concise summary of the influenza genome and the principal functions of the proteins which are encoded. Segments are conventionally numbered from 1 to 8 in descending order of length.

Three viral proteins - PB1, PB2, and PA - associate to form the RNA-dependent RNA polymerase (RdRp) which functions to transcribe and replicate the viral RNA.
Viral messenger RNA Transcription - The RdRp complex transcribes viral mRNAs by using a mechanism called cap-snatching. It consists in the hijacking and cleavage of host capped pre-mRNAs. Host cell mRNA is cleaved near the cap to yield a primer for the transcription of positive-sense viral mRNA using the negative-sense viral RNA as a template. The host cell then transports the viral mRNA into the cytoplasm where ribosomes manufacture the viral proteins.
Replication of the viral RNA -The replication of the influenza genome involves two steps. The RdRp first of all transcribes the negative-sense viral genome into a positive-sense complimentary RNA (cRNA), then the cRNAs are used as templates to transcribe new negative-sense vRNA copies. These are exported from the nucleus and assemble near the cell membrane to form the core of new virions.




Surface encoding gene segments


All influenza A viruses have two gene segments titled HA and NA which code for the antigenic proteins hemagglutin and neuraminidase which are located on the external envelope of the virus.




= HA

=
HA codes for hemagglutinin, which is an antigenic glycoprotein found on the surface of the influenza viruses and is responsible for binding the virus to the cell that is being infected. Hemagglutinin forms spikes at the surface of flu viruses that function to attach viruses to cells. This attachment is required for efficient transfer of flu virus genes into cells, a process that can be blocked by antibodies that bind to the hemagglutinin proteins. One genetic factor in distinguishing between human flu viruses and avian flu viruses is that avian influenza HA bind to alpha 2-3 sialic acid receptors while human influenza HA bind alpha 2-6 sialic acid receptors.




= NA

=
NA codes for neuraminidase which is an antigenic glycoprotein enzyme found on the surface of the influenza viruses. It helps the release of progeny viruses from infected cells. The antiviral drugs Tamiflu and Relenza work by inhibiting some strains of neuraminidase.




Matrix encoding gene segments






= M

=
M codes for the matrix proteins (M1 and M2) that, along with the two surface proteins (hemagglutinin and neuraminidase), make up the capsid (protective coat) of the virus. It encodes by using different reading frames from the same RNA segment.

The matrix protein M1 forms the capsid, which coats the viral nucleoproteins and supports the structure of the viral envelope. M1 also assists with the function of the NEP protein.
The M2 protein forms a proton channel in the viral envelope that uncoats the virus, thereby exposing its contents (the eight RNA segments) to the cytoplasm of the host cell. The M2 transmembrane protein is an ion channel required for efficient infection.




Nucleoprotein encoding gene segments.






= NP

=
NP codes for a structural protein which encapsidates the negative strand viral RNA.




= NS

=
NS codes for two nonstructural proteins (NS1 and Nuclear Export Protein NEP - formerly called NS2).

NS1 counteracts the host’s natural immune response and inhibits interferon production.
NEP mediates the export of influenza virus ribonucleoprotein (RNP) complexes from the nucleus into the cytoplasm, where they are assembled..




Polymerase encoding gene segments






= PA

=
PA codes for the PA protein which is a component of the viral polymerase.




= PB1

=
PB1 codes for the PB1 protein and the PB1-F2 protein.

The PB1 protein is a component of the viral polymerase.
The PB1-F2 protein is encoded by an alternative open reading frame of the PB1 RNA segment




= PB2

=
PB2 codes for the PB2 protein which is a component of the viral polymerase.




Mutation






See also


Fujian flu
Goose Guangdong virus
Orthomyxoviridae




References






Further reading






External links






External links


Influenza Research Database – Database of influenza genomic sequences and related information.

Kata Kunci Pencarian:

• Influenza
• H5N1 genetic structure
• H5N1 vaccine
• Influenza A virus subtype H5N1
• 2020–2024 H5N1 outbreak
• Human mortality from H5N1
• Global spread of H5N1
• Avian influenza
• Transmission and infection of H5N1
• Global spread of H5N1 in 2005
• Hemagglutinin (influenza)